Isotretinoin, best known by the brand name Accutane (no longer on the market, but the name persists colloquially), is, by any objective measure, the most transformative acne treatment in existence. For patients with severe, cystic, or scarring acne who have not responded to other treatments, it offers the realistic possibility of long-term remission.
What Is Isotretinoin?
Isotretinoin is an oral retinoid, a vitamin A derivative, that works through four parallel mechanisms: 1. Dramatically reduces sebum production, by up to 90% 2. Normalizes follicular keratinization, prevents the cellular debris buildup that forms comedones 3. Inhibits C. acnes, through the sebum-depleted environment 4. Anti-inflammatory effects, independent of sebum reduction
No other single agent addresses all four pathophysiological drivers of acne simultaneously.
Who Is Isotretinoin For?
Dermatology guidelines recommend isotretinoin for: – Severe nodular or cystic acne – Moderate acne that has not responded to antibiotics plus topical retinoids – Acne causing significant scarring – Acne causing significant psychological distress despite treatment
Common Side Effects
Mucocutaneous dryness is nearly universal: – Dry lips (cheilitis), managed with frequent lip balm – Dry skin, dry eyes, dry nasal passages – Increased photosensitivity
Elevated liver enzymes and triglycerides, monitored by regular blood tests.
iPLEDGE: The Mandatory Safety Program
Isotretinoin is a proven teratogen (causes severe birth defects). All patients must be enrolled in the iPLEDGE program, requiring pregnancy prevention measures and monthly negative pregnancy tests for females of reproductive potential.
Outcomes
Approximately 85% of patients achieve significant or complete clearance after one course. Relapse rates are lower with cumulative dose-based treatment.
NuLine enrolls adults 18–44 in acne clinical trials evaluating novel approaches. Apply today.